Making a global impact in the fight against lung disease - Institute for Respiratory Health

Making a global impact in the fight against lung disease

Monday, May 15, 2023 | News

As the world celebrates International Clinical Trials Day on Friday 19 May, the Institute for Respiratory Health is proud to be leading the fight against lung diseases by forging partnerships with top healthcare and pharmaceutical companies across the globe.

With chronic lung diseases being one of the leading causes of death in Australia, the need for more research to discover new cures and treatments has never been more vital.

Through pioneering research studies and being part of clinical trials for innovative medicines like Trikafta, the Institute for Respiratory Health is making a significant impact on the lives of patients around the world.

Meagan Shorten, clinical trials manager said, “The Institute in Western Australia may not be a household name but the care that we deliver in helping to save lives is recognised globally.

“Some of the work on the game-changing medicine Trikafta was undertaken with volunteers right here in Perth. Without research, the drug wouldn’t be available today, which is why the work we do is so crucial.

“But we couldn’t do our life-saving work without patients, over the past two decades we’ve worked with more than 2,400 selfless volunteers who are the first to benefit from new and emerging treatments and their participation helps others with chronic lung conditions.”

The Institute has undertaken more than 250 research studies across asthma, COPD, bronchiectasis and cystic fibrosis to name a few, to discover new devices and treatments to help find new cures and treatments.

“We have a strong track record of success, outstanding facilities, world-class respiratory doctors and nurses and like to lead the way in respiratory clinical trials,” Shorten added.

“A big part of our success is our dedicated researchers and nurses who have made possible the breakthrough treatments and new therapies we have today.”

The Institute for Respiratory Health remains committed to continuing the legacy of James Lind, who began trials into the causes of scurvy in 1747 and advancing global clinical research towards a better future for those with lung conditions.

Media contact:

Andrea Jones – 0450613460
Redhead Digital Marketing